top of page
The HER2 Hurdle: Molecular Profiling and Emerging HER2 Targeted Therapies for Patients with NSCLC
Mon, Mar 02
|Zoom
Presented by Dr. Dietrich Hosted by Med Learning Group
Time & Location
Mar 02, 2026, 6:30 PM – 7:30 PM
Zoom
About The Event
A Grand Round Series entitled
"The HER2 Hurdle: Molecular Profiling and Emerging HER2 Targeted Therapies for Patients With NSCLC” “
Hosted by Med Learning Group
Presented by Dr. Dietrich
Learning objectives:
Describe the distinctions between HER2 alterations as well as the prevalence, patient population, and burden of disease for HER2-mutant NSCLC
bottom of page